The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone

Table 5 Known group validity of EQ-5D-3L values by stroke severity measured by NIHSS, significance test: Kruskal–Wallis

Stroke severity	EQ-5D-3L seven days median (IQR)	EQ-5D-3L 90 days median (IQR)	EQ-5D-3L One year median (IQR)
Mild stroke	0.56 (0.26–0.78)	0.87 (0.59–1.0)	1.0 (0.59–1.0)
Moderate stroke	0.17 (-.06–0.71)	0.69 (0.33–1.0)	0.66 (0.38–1.0)
Severe stroke	-0.06 (-0.33–0.26)	0.59 (0.19–1.0)	0.71 (0.31–1.0)
	chi2 = 72.1 p = < 0.001	Chi2 = 17.2 p = < 0.001	Chi2 = 20.6 p = < 0.001

ISSN: 1477-7525